Newsroom

octobre 7, 2022

AXAHALER, SMB’s proprietary DPI Device Shows Its Superiority over other Devices

An independent study has shown that Laboratoires SMB’s Axahaler has a superior delivered dose when compared to other devices. The Fine Particle Dose, the respirable dose critical
septembre 15, 2022

LABORATOIRES S.M.B. S.A. Successfully Concluded A Clinical Trial for Cholecalciferol

Laboratoires S.M.B.S.A. is the first company that has successfully concluded a study to show that its Vitamin D product positively impacts the clinical outcome of hospitalized COVID-19 patients.
logo blanc